Unitree's IPO is 8,000x oversubscribed — the humanoid mania now carries a 219x-earnings price tag.

Unitree's initial public offering has turned into a mania. When the Hangzhou humanoid maker — registered as Yushu Technology — opened retail subscriptions on Shanghai's STAR Market on Monday, August 10, individual investors submitted about 9.78 million orders and the online tranche was initially oversubscribed 8,288.82 times, so far above the threshold that it triggered a clawback shifting roughly 3.2 million shares from institutions to retail. Even after that, the retail portion remained about 5,526 times oversubscribed, leaving a lot-winning rate of just 0.018% — roughly one allotment for every 5,526 attempts. By Bloomberg's calculation, retail orders totaled around 8.1 trillion yuan (about $1.2 trillion), exceeding the order book of chipmaker CXMT's blockbuster listing last month. Unitree priced the deal a week earlier at 150.8 yuan (about $22) a share — roughly a 61 billion yuan, or $9 billion, valuation — selling about 40.45 million new shares, or 10%, to raise near 6.1 billion yuan ($904 million), with AI company DeepSeek among its strategic investors.

That demand is stacked on a demanding price. At the IPO valuation, Unitree is worth about 219 times its 2025 earnings and 36 times sales — multiples that assume years of flawless execution. Analysts are openly split. SWS Research suggested the listing could drive 'a repricing of robotics-related stocks,' and one Hangzhou investor told Reuters he expected the shares to 'multiply by several times on debut.' Others were blunt about the risk: Wang Zhuo of Shanghai Zhuozhu Investment Management called the IPO 'expensive' with investment risk 'already quite high,' noting Unitree still earns much of its money from research and demonstration units rather than broad commercial use, while Xiangcai Securities warned the company must 'keep growing rapidly to justify its rich valuations.' As of the window's close, Unitree had not even set its first day of trading.

The froth also sits awkwardly against the fundamentals. Separate industry data released the same week showed Unitree had just ceded its crown as the world's top humanoid shipper to Shanghai rival AgiBot in the first half of 2026, and Unitree's own prospectus shows first-quarter 2026 profit, excluding one-off items, fell by more than half even as revenue climbed. The company counts the United States among its key markets and has flagged geopolitical risk as material: the FCC added foreign humanoids to its Covered List on July 28, China's commerce ministry threatened countermeasures, and more than 40% of Unitree's turnover has come from overseas. Unitree plans to spend about 4.2 billion yuan of the proceeds on robot-model research, hardware development, new products and a manufacturing base.

For a buyer, the oversubscription changes the financing picture, not the shopping list. It confirms the sector is priced for perfection — a market-set humanoid valuation of 219 times earnings leaves no margin for the reliability, dexterity and endurance gaps that still keep most shipped robots in labs and demos rather than doing paid work. Two practical implications follow. A cash-rich, publicly traded Unitree can keep driving prices down — the G1 sits around $13,500 and the R1 around $4,900 — and volume up, which helps research and education buyers, even as U.S. procurement stays gated by the FCC ban on new foreign models. And once Unitree files quarterly reports, buyers and rivals will finally get audited-style numbers on what a high-volume humanoid business actually earns. Watch those margins, and the gap between the first-day pop and the fundamentals, far more closely than the retail frenzy.